MW MEDICAL INC
NT 10-K, 2000-03-30
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: LMI AEROSPACE INC, 10-K, 2000-03-30
Next: TRANSNATIONAL FINANCIAL CORP, 10KSB, 2000-03-30



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                   FORM 12b-25

                        Commission File Number 001-14297

                           Notification of Late Filing


                                  (Check One):

  [X] Form  10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q  [ ] Form N-SAR

      For Period Ended:         December 31, 1998
          [ ]  Transition  Report on Form  10-K
          [ ]  Transition  Report  on Form  20-F
          [ ]  Transition  Report on Form 11-K
          [ ]  Transition   Report  on  Form  10-Q
          [ ]  Transition Report on Form N-SAR
      For the Transition Period Ended:



Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.



If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:



                         Part I - Registrant Information

                    Full Name of Registrant: MW Medical, Inc.

                            Former Name if Applicable

                        6617 N. Scottsdale Rd., Suite 103
            Address of Principal Executive Office (Street and Number)

                         Scottsdale, Arizona 85250
                          City, State and Zip Code



                                        1

<PAGE>



                        Part II - Rules 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check box if appropriate)

[X]  (a) The reasons  described in reasonable detail in Part III of this
         form could not be eliminated without unreasonable effort or expense;

[X]  (b) The  subject  annual  report,  semi-annual  report,  transition
         report on Form 10-K, Form 20-F, 11-K or Form N- SAR, or portion thereof
         will be filed on or before the  fifteenth  calendar day  following  the
         prescribed  due date;  or the subject  quarterly  report or  transition
         report on Form 10-Q, or portion  thereof will be filed on or before the
         fifth calendar day following the prescribed due date; and

[X]  (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
         has been attached if applicable.


                              Part III - Narrative

State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K,
10-Q,  N-SAR,  or the  transition  report or portion  thereof  could not be file
within the prescribed period.

                  Auditor is not done with the audit.

                           Part IV - Other Information

(1) Name and telephone number of person to contract in regard to this
notification.

                 Grace Sim      (480)                      315-8600
                  (Name)      (Area Code)              (Telephone Number)

(2) Have all other periodic  reports required under section 13 or 15(d)
of the Securities  Exchange Act of 1934 or section 30 of the Investment  Company
Act of 1940 during the  preceding 12 months or for such shorter  period that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).

                                                                [X] Yes   [ ] No

(3) Is it  anticipated  that  any  significant  change  in  results  of
operations  from the  corresponding  period  for the last fiscal year will be
reflected by the  earnings  statements  to be included in the subject report or
portion thereof?

                  Income is uncertain until audit is finished.
                                                                [X] Yes   [ ] No

If  so:  attach  an  explanation  of  the  anticipated change, both
narratively and  quantitatively,  and, if  appropriate, state the reasons why a
reasonable estimate of the results cannot be made.

                                MW Medical, Inc.
                  (Name of Registrant as specified in charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.


Date:  March 29, 2000
                                         /s/ Grace Sim
                                         --------------------------
                                         By: Grace Sim, Secretary


                                        2






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission